Test Code Billings Clinic: 8616 Mayo: B2M Beta-2-Microglobulin, Serum
Reporting Name
Beta-2-Microglobulin, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Prognosis assessment of multiple myeloma
Evaluation of renal tubular disorders
Method Name
Nephelometry
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Type
SerumSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 14 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
1.21-2.70 mcg/mL
Interpretation
A serum beta-2-microglobulin (beta-2-M) value of less than 4 mcg/mL is a good prognostic factor in patients with multiple myeloma. In a study of pretreatment serum beta-2-M levels in 100 patients with myeloma, it was reported that the median survival of patients with values greater than 4 mcg/mL was 12 months, whereas median survival for patients with values less than 4 mcg/mL was 43 months.
Day(s) Performed
Monday through Friday
Report Available
Same day/1 to 2 daysTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82232
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
B2M | Beta-2-Microglobulin, S | 1952-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
B2M | Beta-2-Microglobulin, S | 1952-1 |
Forms
If not ordering electronically, complete, print, and send Renal Diagnostics Test Request (T830)
Testing Algorithm
For more information, see Multiple Myeloma: Laboratory Screening